With a Focus on Potential Pivotal Studies in 2025, Treadwell has Strengthened its Leadership Team by Appointing Brenda Marczi, PharmD, MBA as SVP and Head of Regulatory AffairsTORONTO & SAN FRANCISCO (BUSINESS WIRE) Treadwell Therapeutics, a privately held clinical-stage biotechnology company pioneering and advanc.